Company Filing History:
Years Active: 2009-2012
Title: Innovator Spotlight on Emily C Mundorff: Pioneering Advances in Recombinant Technology
Introduction
Emily C Mundorff, an accomplished inventor based in Milwaukie, Oregon, has made significant strides in the field of recombinant polypeptides and nucleic acids. With a total of three patents to her name, her work focuses on optimizing crossover points for directed evolution, offering innovative solutions to engineering diversity in molecular sequences.
Latest Patents
Among her latest patents, Emily Mundorff's work titled "Optimization of Crossover Points for Directed Evolution" stands out. This patent encompasses methods and devices aimed at engineering diversity more efficiently into recombinant polypeptides and nucleic acids. It outlines a variety of methods for selecting and assessing potential crossover sites in both amino acid and nucleotide sequences. The patent highlights the importance of considering structural, functional, and statistical data in the selection process, ultimately leading to the development of valuable chimeric product sequences.
Career Highlights
Emily has had an impressive career, having worked with prominent companies in the biotechnology sector, including Codexis, Mayflower Holdings LLC, and Maxygen, Inc. Throughout her professional journey, she has focused on leveraging her expertise in molecular biology and recombinant technology to push the boundaries of innovation in her field.
Collaborations
Collaboration has been a key component of Emily's success. She has worked alongside distinguished colleagues such as Sridhar Govindarajan and Claes Gustafsson. These partnerships have facilitated the sharing of knowledge and expertise, greatly enhancing the quality and impact of her inventions.
Conclusion
Emily C Mundorff exemplifies the spirit of innovation in the biotechnology sector. Her contributions through her patents and collaborations reflect her commitment to advancing the science of recombinant engineering. As she continues to push the envelope in her field, her work promises to shape the future of biotechnology and its applications.